Valuation: Oscotec Inc.

Market Cap 1,337B 949M 821M 766M 703M 1.32B 90.29B 1.34B 8.99B 3.53B 45.25B 3.56B 3.48B 150B P/E 2026 *
41.6x
P/E 2027 * 11.2x
Enterprise Value 1.15B 817K 707K 660K 606K 1.14M 77.8M 1.16M 7.75M 3.04M 38.99M 3.07M 3M 129M EV / Sales 2026 *
13.7x
EV / Sales 2027 * 5.38x
Free-Float
71.79%
Yield 2026 *
-
Yield 2027 * -
1 day-1.13%
1 week+16.31%
Current month+16.31%
1 month+12.02%
3 months-31.47%
6 months-30.52%
Current year-22.68%
1 week 30,750
Extreme 30750
36,250
1 month 27,300
Extreme 27300
36,250
Current year 27,300
Extreme 27300
60,200
1 year 27,300
Extreme 27300
66,000
3 years 18,000
Extreme 18000
66,000
5 years 15,850
Extreme 15850
66,000
10 years 5,630
Extreme 5630
71,500
Manager TitleAgeSince
Chief Executive Officer 63 2020-03-25
Corporate Officer/Principal 54 1999-08-31
Chief Tech/Sci/R&D Officer 62 -
Director TitleAgeSince
Director/Board Member 54 1999-08-31
Director/Board Member 63 2020-03-25
Director/Board Member 66 2023-03-29
Date Insider Type Main position Quantity % Market Cap.
7/24/25 Buy 500 0.0013%
Change 5-day change 1-year change 3-year change Capi.($)
-1.13%+16.31%+11.84%+2.95% 949M
+0.16%-1.24%+59.35%+21.19% 317B
+0.07%+0.84%+33.01%-12.94% 72.2B
+20.24%+24.93%+63.94%+141.90% 11.7B
+0.63%+1.87%-2.19%-3.95% 8.45B
+2.28%+8.10%-14.26%-14.00% 4.75B
+14.37%+22.10%+4.25%+50.44% 4.38B
+3.60%+9.66%-28.04%+8.36% 4.26B
+1.88%+6.74%+15.55%+56.04% 2.77B
+4.26%+0.31%+1.17%+0.23% 2.26B
Average +4.77%+8.71%+14.46%+25.02% 42.9B
Weighted average by Cap. +1.92%+0.34%+50.89%+18.10%

Financials

2026 *2027 *
Net sales 84B 59.6M 51.55M 48.14M 44.16M 83.06M 5.67B 84.38M 565M 222M 2.84B 224M 219M 9.4B 192B 136M 118M 110M 101M 190M 12.96B 193M 1.29B 507M 6.5B 512M 500M 21.48B
Net income 32B 22.7M 19.64M 18.34M 16.82M 31.64M 2.16B 32.15M 215M 84.45M 1.08B 85.26M 83.39M 3.58B 119B 84.43M 73.03M 68.2M 62.56M 118M 8.04B 120M 800M 314M 4.03B 317M 310M 13.31B
Net Debt -185B -131M -114M -106M -97.26M -183M -12.49B -186M -1.24B -488M -6.26B -493M -482M -20.7B -304B -216M -187M -174M -160M -301M -20.53B -305M -2.04B -802M -10.29B -810M -792M -34.01B
Logo Oscotec Inc.
Oscotec Inc is a Korea‑based company primarily engaged in new drug development business. The Company operates four main businesses. The new drug development business primarily mainly researches and develops synthetic new drugs, including therapies for autoimmune diseases, acute myeloid leukemia, refractory solid tumors, Alzheimer’s disease and next‑generation solid tumor treatments designed to overcome drug resistance. The dental bone graft business primarily supplies bone graft materials. The dental barrier membrane business provides own developed absorbable collagen barrier membranes. The functional materials and related products business primarily provide functional materials for osteoporosis prevention and bone health, materials and finished products for arthritis prevention and alleviation, and functional materials for periodontal disease prevention and alleviation.
Employees
55
Date Price Change Volume
26-08-07 ₩34,950.00 -1.13% 116,396
26-08-06 ₩35,350.00 +5.21% 207,155
26-08-05 ₩33,600.00 -2.89% 143,128
26-08-04 ₩34,600.00 +12.16% 259,788
26-08-03 ₩30,850.00 +2.66% 180,536
Trader
Investor
-
Global
-
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
34,950.00KRW
Average target price
75,000.00KRW
Spread / Average Target
+114.59%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A039200 Stock